Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Krane Offers China Healthcare ETF with China, Hong Kong, US-listed Companies

publication date: Feb 2, 2018

The KraneShares MSCI All China Health Care Index ETF has begun trading on the New York Stock Exchange. KraneShares, an ETF (Exchange Traded Fund) provider with several China ETFs already available, offers the ETF to people who want to invest in China's health care industry. The ETF will mimic the performance of the MSCI All China Health Care Index, including healthcare companies listed in Shanghai, Shenzhen, Hong Kong and the US. Small, medium and large-cap companies are included in the list. More details....

Stock Symbol: (NYSEArca: KURE)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital